Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Legalization could still be years away from becoming a reality.

Why Tilray Investors Shouldn't Get Their Hopes Up on Legalization

Aurora Cannabis

Canopy Growth

Tilray announced progress on adult-use legalization today, but it wasn't for the key U.S. market.

Why Tilray, Canopy Growth, and Aurora Cannabis Dropped Today

Evogene

HEXO Corp

Innovative Industrial Properties

SNDL Inc.

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

5 Weed Stocks That Smoked Headlines This Week

Tilray Brands faces a shareholder lawsuit from the Aphria merger. The Canadian cannabis company still fails to generate revenue growth over a year after the merger closed.

Tilray Brands: No One Is Happy

OrganiGram Holdings Inc.

Aurora Cannabis, Canopy Growth, OrganiGram Holdings, and Tilray Brands are all in the red yet again today.

Why Pot Stocks Are Going Up In Smoke Today

TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life today announced the expansion of Good Supply 's award-winning cannabis portfolio. The brand's latest product drop includes new high-potency concentrates Jean Guy Badder, Hash Bats in Pineapple Express, and Orange Frost Live Resin, available for a limited time.

Good Supply Launches New High-Potency Product Drop and Unveils Exclusive Orange Frost Live Resin

AMC Entertainment

Carvana

DraftKings

GameStop

Lucid Group

Marathon Digital Holdings

Roundhill Meme ETF

Novavax

Invitae

If you think investing in "meme stocks" is like playing a game of musical chairs, you might be surprised at how quickly the music might stop. The post 9 Key Meme Stocks To Run Out Of Money In Less Than 2 Years appeared first on Investor's Business Daily.

9 Key Meme Stocks To Run Out Of Money In Less Than 2 Years

Cronos Group

Top Marijuana Stocks To Buy This Week? The post 3 Canadian Marijuana Stocks To Watch Heading Into September appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch Heading Into September

Major cannabis reforms in the U.S. are unlikely in the near term, according to a key senator.

Why Tilray, Canopy Growth, and Aurora Cannabis Are Stumbling Today

Federal legalization of marijuana in the U.S. is far from imminent, but some progress could be close.

Why Tilray Shares Jumped Today

These three pot stocks appear to be beneficiaries of a bear market rally today.

Why Aurora Cannabis, Canopy Growth, and Tilray Are Glowing Green Today

Destination XL Group

Esports Entertainment Group

Liberty TripAdvisor Hlds

Transocean

UpHealth

Regardless of economic cycles, investing in cheap penny stocks is always a good idea. After all,  some of the blue-chip stocks we love today started off as penny stocks, making their early investors tremendous amounts of money.

7 Cheap Penny Stocks to Buy Before They Boom

This top marijuana stock has seen a lot of volatility in recent years.

Tilray Brands: Bull vs. Bear

Natural Health Science Foundation Assessment Further Verifies Tilray Medical's High-Quality Standard and its CBD100 Product for Clinical Trial Use Natural Health Science Foundation Assessment Further Verifies Tilray Medical's High-Quality Standard and its CBD100 Product for Clinical Trial Use

Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia and New Zealand

2 Marijuana Stocks To Buy Or Sell This Week? The post Top Canadian Marijuana Stocks To Buy Today? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Buy Today?

Best Buy

Sandstorm Gold

With bullish sentiment steadily creeping back into the market, speculators may be eyeballing undervalued meme stocks to buy. Just to set the tone, Augsburg University defines this investment category as any security “that's seen its price skyrocket due to excessive trading volume from retail investors.

3 Undervalued Meme Stocks to Buy Before the Next Surge

Investors were initially euphoric about the opening of a new market abroad.

Why Tilray Stock Popped Then Dropped Today

Investors should prepare for lots of dilution.

Why Tilray Could End Up Going on an Acquisition Spree

Polish Ministry of Health Approves Tilray Branded Medical Cannabis for Pharmaceutical Distribution in Addition to Wholesale Approval Polish Ministry of Health Approves Tilray Branded Medical Cannabis for Pharmaceutical Distribution in Addition to Wholesale Approval

Tilray Medical Bolsters Market Leading Position in Europe With Market Authorization in Poland

Hut 8 Mining Corp

With the risk-off trade dominating amid economic uncertainty, investors' enthusiasm for penny stocks has dwindled. The focus has instead been on blue chips and deeply undervalued growth stocks.

3 Penny Stocks That Could Go Parabolic

Tilray's CEO pegs the U.S. cannabis market at $100 billion.

Why Tilray, Canopy Growth, and Aurora Cannabis All Spiked Today

2 Marijuana Stocks To Watch In A Volatile Market The post 2 Marijuana Stocks To Watch To Start Your Trading Day appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Watch To Start Your Trading Day

The legalization of marijuana at the federal level will be a $100 billion opportunity extending beyond just recreational and medical use, says Tilray CEO Irwin Simon.

Cannabis in US is a ‘$100 billion opportunity,' Tilray CEO Irwin Simon says

Camber Energy

Houston American Energy

Insignia Systems

Mullen Automotive

Phunware Inc

Wish

With the meme stock mania in the rear-view mirror and the equities market in shambles, it's probably a good time to think about penny stocks to avoid. Several penny stocks caught fire last year as part of the retail trading frenzy.

7 Penny Stocks to Avoid in August

Regulators just gave the cannabis industry a big and positive clue about their intentions.

Could This Enigmatic Statement Lead to Marijuana Legalization in the E.U.

News for Tilray Brands Stock (TLRY)